Improving adherence to best-practice guidelines for venous thromboembolism risk assessment and prevention

American Journal of Health-System Pharmacy

Volumn 68, Issue 22, 2011, Pages 2184-2189

  Schiro, Timothy A ^a   Sakowski, Julie ^b   Romanelli, Robert J ^e   Jukes, Trevor ^c   Newman, Jeffrey ^b,d   Hudnut, Andrew ^a   Leonard, Thomas ^a  

^a SUTTER HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHSS   (United States)

^d Shire Pharmaceuticals   (United States)

^e Sutter Health Institute for Medical Research ^*

Author keywords

Anticoagulants; Compliance; Contraindications; Hospitals; Nurses; Protocols; Quality assurance; Risk management; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULATION; ARTICLE; HIGH RISK PATIENT; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; NURSE; PATIENT COMPLIANCE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SCORING SYSTEM; VENOUS THROMBOEMBOLISM;

EID: 81155128108     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110102     Document Type: Article

References (24)

1. Silverstein MD, Heit JA, Mohr DN et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998; 158:585-93. (Pubitemid 28144815)
2. White RH, Henderson MC. Risk factors for venous thromboembolism after total hip and knee replacement surgery. Curr Opin Pulm Med. 2002; 8:365-71. (Pubitemid 34836938)
3. Office of the Surgeon General. Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. www.surgeongeneral.gov/ topics/deepvein/ (accessed 2011 Jun 2).
4. Cundiff DK. Anticoagulation therapy for venous thromboembolism. MedGenMed. 2004; 6(3):5.
5. Hull RD, Feldstein W, Stein PD et al. Cost-effectiveness of pulmonary embolism diagnosis. Arch Intern Med. 1996; 156:68-72. (Pubitemid 26011592)
6. Cohn SL. Prophylaxis of venous thromboembolism in the US: improving hospital performance. J Thromb Haemost. 2009; 7:1437-45.
7. Anderson FA Jr, Wheeler HB, Goldberg RJ et al. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992; 152:1660-4.
8. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(suppl):338S-400S. (Pubitemid 39302602)
9. Agency for Healthcare Research and Quality. Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement, August 2008. www.ahrq.gov/qual/vtguide/vtguide.pdf (accessed 2011 Jun 2).
10. Geerts WH, Bergqvist D, Pineo GF. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133(suppl):381S-453S. (Pubitemid 351894916)
11. Agency for Healthcare Research and Quality. Making health care safer: a critical analysis of patient safety practices. Evidence report/technology assessment. July 20, 2001. http://archive.ahrq.gov/clinic/ptsafety/pdf/ptsafety. pdf (accessed 2011 Jan 12).
12. National Institute for Health and Clinical Excellence. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery, April 2007. www.nice.org.uk/CG046 (accessed 2011 Jun 2).
13. Amin A, Stemkowski S, Lin J et al. Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost. 2007; 5:1610-6. (Pubitemid 47091400)
14. Amin AN, Stemkowski S, Lin J et al. Preventing venous thromboembolism in US hospitals: are surgical patients receiving appropriate prophylaxis? Thromb Haemost. 2008; 99:796-7. (Pubitemid 351694244)
15. Cohen AT, Tapson VF, Bergmann JF et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008; 371:387-94. [Erratum, Lancet. 2008; 371:1914.] (Pubitemid 351173321)
16. Maynard G, Stein J. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis. 2010; 29:159-66.
17. Caprini JA, Tapson VF, Hyers TM et al. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg. 2005; 42:726-33. (Pubitemid 41483500)
18. Niemi K, Geary S, Quinn B et al. Implementation and evaluation of electronic clinical decision support for compliance with pneumonia and heart failure quality indicators. Am J Health-Syst Pharm. 2009; 66:389-97.
19. International Classification of Diseases, 9th revision, Clinical Modification Searchable Database. Homepage. http:// icd9cm.chrisendres.com (accessed 2011 Jul 7).
20. Kucher N, Koo S, Quiroz R et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005; 352:969-77.
21. Galanter WL, Thambi M, Rosencranz H et al. Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital. Am J Health-Syst Pharm. 2010; 67:1265-73.
22. Moote M, Englesbe M, Bahl V et al. PA-driven VTE risk assessment improves compliance with recommended prophylaxis. JAAPA. 2010; 23(6):27-30,32-5.
23. Bauer JB, Chun DS, Karpinski TA. Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital. Am J Health-Syst Pharm. 2008; 65:1643-7.
24. Sobieraj DM, White CM, Coleman CI. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther. 2008; 30:1416-25.